Add like
Add dislike
Add to saved papers

Cervical Laminoplasty versus Laminectomy and Fusion: A Comprehensive Time-Driven Activity-Based Cost Analysis.

Spine 2024 September 5
STUDY DESIGN: Retrospective study.

OBJECTIVE: To compare the true cost between posterior cervical laminectomy and fusion and cervical laminoplasty using time driven activity-based costing methodology.

SUMMARY OF BACKGROUND DATA: Cervical laminoplasty (LP) and posterior cervical laminectomy with fusion (LF) are effective procedures for treating cervical myelopathy. A comprehensive accounting of cost differences between LP versus LF is not available. Using time-driven activity-based costing (TDABC), we sought to compare the total facility costs in patients with cervical myelopathy undergoing LP versus LF.

METHODS: We conducted a retrospective analysis of 277 LP and 229 LF performed between 2019 and 2023. Total facility costs, which included personnel and supply costs, were assessed using TDABC. Separate analyses including and excluding implant costs were performed. Multiple regression analysis was utilized to assess the independent effect of LP compared to LF on facility costs, with all costs standardized using cost units (CUs).

RESULTS: Patients undergoing LP had lower total supply costs (672.5 vs. 765.0 CUs [0.88x], P<0.001) and lower total personnel costs (330.0 vs. 830.0 CUs [0.40x], P<0.001), resulting in a lower total facility cost both including (1,003.8 vs. 1,600.0 CUs [0.63x], P<0.001) and excluding implant costs (770.0 vs. 875.0 CUs [0.88x], P<0.001) (Table 1). After controlling for demographics and comorbidities, LF was associated with increased total facility costs, including (588.5 CUs, 95% CI 517.1-659.9 CUs, P<0.001) and excluding implant costs (104.3 CUs, 95% CI 57.6-151.0 CUs, P<0.001).

CONCLUSION: Using time-driven activity-based costing, we found that total facility costs were lower in patients treated with laminoplasty. These findings suggest that laminoplasty may offer a less costly and more efficient surgical option for treating cervical myelopathy.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app